Introduction
Phosphatidylinositol-3-kinase gamma (PI3Kγ) is a member of the PI3K family that phosphorylates phosphatidylinositol 4,5-diphosphate to generate phosphatidylinositol 3,4,5-triphosphate (PIP3) at the plasma membrane [1] . PIP3 serves as a docking station to recruit signaling proteins containing the pleckstrin homology domain for initiation of signaling events [2] . PI3K family can be categorized into class I, II, and III, whereas class I PI3K is further divided into class IA and IB subsets [1, 3] . Class IA PI3K consists of three members PI3Kα, PI3Kβ, and PI3Kδ. PI3Kγ is the only member in the class IB subset and it is a heterodimer composed of a catalytic subunit p110γ and one of the two regulatory subunits p101 and p84. PI3Kγ is involved in G protein-coupled receptor (GPCR) signaling through interaction with G protein subunit G βγ [4, 5] . Although low levels of PI3Kγ have been found in cardiomyocytes, PI3Kγ expression is otherwise restricted to the hematopoietic lineage, suggesting its functional importance in leukocytes [6, 7] .
PI3Kγ is involved in T-cell development in the thymus but its role in T-cell activation has been controversial [8] . Although T cells from PI3Kγ-deficient mice have been reported to be defective in proliferation and cytokine production [8] [9] [10] , other studies with independently generated PI3Kγ-deficient mice demonstrated a normal T-cell proliferative response [11, 12] . A number of PI3Kγ kinase inhibitors have been shown to block T-cell functions but interpretation of PI3Kγ biology from compound effects is limited by the target selectivity of compounds [13] . Further investigations of PI3Kγ function in T cells with alternative approaches are therefore warranted.
Upon TCR engagement, multiple signaling mechanisms including NFAT, NF-κB, and MAPK pathways are activated, which result in gene induction and cell cycle progression. Generation of PIP3 is one of the earliest signals observed in activated T cells [14, 15] . Class IA PI3K members could be recruited to TCR complex via their regulatory subunits [16] [17] [18] [19] . Costimulatory receptors CD28 and ICOS have class IA PI3K binding motifs YXXM on their cytoplasmic domains [20, 21] . Class IA PI3K activity in T cells has also been suggested to be downregulated by PIK3IP1 [22] . Protein kinase B (AKT) is a serine threonine kinase downstream of PI3K and it has been reported to modulate NF-κB signaling pathway during T-cell activation [23] . Although activated T cells from PI3Kγ-deficient mice show a reduced phosphorylation of AKT and ERK, details on how PI3Kγ is recruited in TCR signaling remain unclear [9] .
PI3K has been shown to play a role in T-cell differentiation through TORC1/TORC2 signaling pathways and transcription factors Forkhead box (FOXO) and Krueppel-like factor 2 (KLF2) [24, 25] . Expression of Th17 cytokine IL-17A by human CCR6 +
CD4
+ T cells can be induced by IL7 and this induction was blocked by PI3K inhibitors [24] . Recently a PI3Kγ inhibitor was reported to block Th17 differentiation in human CD4 + T cells [26] . PI3Kγ-deficient mice were also shown to be protected in a Th17 celldriven psoriasis model [10] . However, the potential role of PI3Kγ in T-cell polarization to different helper T-cell subsets or regulatory T (Treg) cells has not been studied in details. The scaffolding function of PI3Kγ independent of its kinase activity has been demonstrated in the cardiovascular system [7] . However, the majority of reports on the role of PI3Kγ in immune cells have been based on studies of PI3Kγ -deficient mice [8, 27] .
Defects identified from this approach cannot differentiate the biological role of PI3Kγ coming from its kinase activity or adaptor function. Mice defective in PI3Kγ kinase activity (PI3Kγ kinasedead knock-in (PI3Kγ KD/KD )) have been generated by introducing a point mutation into the p110γ gene [7] . In this report, we studied the response of T cells from this mouse line and show that PI3Kγ kinase activity is required for optimal T-cell activation and differentiation. Defects in T-cell response are also observed in immunization and DTH models. These results demonstrate a kinase-dependent role of PI3Kγ in T-cell function and suggest that PI3Kγ could be a target of interest in drug discovery for treatment of inflammation and autoimmune diseases. PI3Kγ kinase inhibitors could, therefore, be beneficial in treatment of T cellmediated autoimmune and inflammatory diseases.
Results
Defective TCR-mediated activation of PI3Kγ KD/KD
T cells
To understand the role of PI3Kγ kinase activity in T-cell response, we studied T cells from PI3Kγ KD/KD mice in different activation conditions. Expression of the kinase-inactive PI3Kγ protein in CD4 + T cells was comparable to wild-type (WT) T cells (Supporting Information Fig. 1 ). Proliferations of PI3Kγ KD/KD CD4 + T cells upon anti-CD3 and anti-CD3/CD28 stimulations were reduced by 68 and 34%, respectively, compared to WT CD4 + T cells (Fig. 1A ).
These cells produced less IL-2 and addition of exogenous IL-2 did not restore their proliferation to normal levels. Similar activation defects were demonstrated in PI3Kγ KD/KD CD8 + T cells as well (Fig. 1B) . Naïve and memory CD4 + T cells from PI3Kγ
KD/KD mice were tested for their requirement of PI3Kγ kinase activity in activation. Both naïve and memory cells showed a reduction in proliferation and cytokine production regardless of their Ag preexposure histories (Fig. 1C) .
Impaired mixed lymphocyte reaction (MLR) and Ag-specific activation of PI3Kγ KD/KD T cells
The requirement of PI3Kγ kinase activity in T-cell activation was further examined in Ag-specific stimulations. In MLRs, CD4 Fig. 2A) .
To evaluate T-cell response to specific Ags, ovalbumin-specific effector T cells were generated from CD4 T cells of ovalbuminimmunized WT and PI3Kγ KD/KD mice after multiple rounds of in vitro ovalbumin restimulation. An ovalbumin dose-dependent recall response was demonstrated in these T cells and the proliferative response of PI3Kγ KD/KD T cells was reduced by 38 to 62% accompanied with a decreased IL-2 production compared to WT T cells (Fig. 2B ). Taken together, we have demonstrated the requirement of PI3Kγ kinase activity for optimal Ag-specific T-cell activation.
Mechanism of reduced activation of PI3Kγ KD/KD T cells
The mechanism of PI3Kγ involvement in T-cell response was investigated in a series of studies to monitor the early downstream events of T-cell activation. Upon anti-CD3 stimulation, phosphorylation of AKT and ERK1/2 in PI3Kγ KD/KD T cells was reduced although the induction kinetics was normal (Fig. 3A) . The peak levels of phosphorylated AKT and ERK1/2 in PI3Kγ KD/KD T cells decreased by 34 and 62%, respectively, compared to WT T cells. These phosphorylation defects, however, were overcome by stimulation with anti-CD3/CD28, possibly due to recruitment of other PI3K members of the class IA family (Fig. 3B ).
In the process of T-cell activation, lipid rafts on T cell are accumulated at the contact area with APC [28] . Anti-CD3-and anti-CD28-coated polystyrene beads can mimic APC effect in initiating lipid raft aggregation on T cells, which can be detected with KD/KD (KD) mice were either not stimulated (NS) or stimulated with immobilized anti-CD3 (1 μg/mL) alone or in combination with soluble anti-CD28 (1 μg/mL) for 2 days in the presence or absence of exogenous IL-2 (100 U/mL). (A-C) T-cell proliferation and secreted IL-2 data are shown as mean + SEM of n = 3, and are representative of two independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001; two-way ANOVA test.
FITC-conjugated cholera toxin B (Fig. 3B) . Lipid raft formation on PI3Kγ KD/KD T cells was 70% reduced when compared to WT T cells (Fig. 3C ). T-cell activation eventually leads to cell cycle progression and the kinetics of cell division was monitored in CFSE-stained T cells. PI3Kγ KD/KD T cells were slower than WT T cells in cell division, with 53% of divided PI3Kγ KD/KD T cells, which were shown as CFSE low cells after 5 days of stimulation, a significant reduction when compared to 70% of divided WT T cells (Fig. 3D ). 
Decreased chemotaxis of PI3Kγ KD/KD T cells toward chemokines
The requirement of PI3Kγ kinase activity in CD4 + T-cell chemotaxis was examined in the transwell migration assay. Chemotaxis of PI3Kγ KD/KD T cells toward chemokines CCL3, CCL19, CCL21, CXCL12, and RANTES was reduced by 55 to 70% compared to WT T cells (Fig. 7) . Expression of the corresponding chemokine receptors on PI3Kγ KD/KD T cells was found to be at normal levels (unpublished data). The results suggest a functional defect in chemotactic response of PI3Kγ KD/KD T cells.
Defective immune response in PI3Kγ KD/KD mice
Our in vitro studies showed that T cells from PI3Kγ KD/KD mice were less effective in activation, differentiation, and chemotaxis.
The physiological importance of PI3Kγ kinase activity was further investigated in two immunization models. PI3Kγ KD/KD and WT mice were immunized with ovalbumin/CFA at the tail base and the immune response in mice was examined 10 days later. The typical response in immunized mice is an enlargement of draining lymph nodes with increased cellularity as a result of expansion of Agspecific T and B cells. Although lymph nodes from PI3Kγ KD/KD mice were enlarged compared to unimmunized mice, their cellularity was 36% less than that from WT immunized mice (Fig. 8A) . The presence of ovalbumin-specific T cells in the draining lymph nodes was demonstrated by a robust proliferation of lymph node cells to ovalbumin stimulation in a dose-dependent manner, whereas the proliferative response of PI3Kγ KD/KD lymph node cells was reduced by 62 to 71% compared to WT cells (Fig. 8B ). This was accompanied by a decrease in cytokine production, with a reduction of 81 to 88% in IL-17A and 62 to 74% in IFN-γ levels (Fig. 8B ). Differentiated Th17, Th1, and Th2 CD4 T cells in the draining lymph nodes were identified by intracellular cytokines IL-17A, IFN-γ, and IL-4, respectively. Th17 and Th1 populations in PI3Kγ KD/KD lymph nodes were reduced by 74 and 52% respectively, whereas the Th2 population was comparable to that in WT lymph nodes (Fig. 8C) . PI3Kγ KD/KD mice were further analyzed in a Th2 immunization model with ovalbumin/alum injection at the tail base and the immune response was analyzed 10 days later. PI3Kγ KD/KD mice mounted an immune response with enlarged draining lymph nodes compared to unimmunized mice, but the cellularity of draining lymph nodes was reduced by 41% compared to that from WT immunized mice (Fig. 9A) . A significant Th2 cell population was generated in this model to allow analysis of Th2 differentiation in PI3Kγ KD/KD mice. The IL-4 + Th2 population in the draining lymph nodes of PI3Kγ KD/KD mice decreased by 38% compared to that in WT mice (Fig. 9B) www.eji-journal.eu 
Impaired DTH response in PI3Kγ
KD/KD mice PI3Kγ KD/KD mice were further characterized in a DTH model to evaluate the importance of PI3Kγ kinase activity in T cell-mediated immune response to Ag reexposure. WT and PI3Kγ KD/KD mice were immunized with methylated BSA (mBSA)/CFA at the tail base. Eleven days postimmunization, the animals were injected at the right hind paws with mBSA to elicit a DTH response, whereas the left hind paws were injected with saline as negative controls. The swelling of Ag-injected paws was measured at different time points up to 48 h postchallenge. PI3Kγ KD/KD mice exhibited an impaired DTH response with a 25% reduction in edema by comparing the area under curve of edema scores with WT mice (Fig. 10A) . Histological examination of mBSA-injected paws revealed an overall 30 to 50% reduction in inflammation, edema, hemorrhage, and necrosis in the paws from PI3Kγ KD/KD mice, compared to those from WT mice (Fig. 10B) . Histopathological examination of WT paws showed a markedly severe inflammation and edema from dorsal to ventral part of the paws. Multiple abscesses in the ventral part were also observed. The majority of infiltrated cells were neutrophils accompanied by small numbers of macrophages and lymphocytes. In contrast, the paws from PI3Kγ KD/KD mice showed a moderate inflammation and edema mostly located in the dorsal part of the paws. There were fewer abscesses in the ventral part of the paw. Most of the infiltrated inflammatory cells were neutrophils and the cell numbers were reduced by 50% of that observed in WT paws (Fig. 10B) . The immune response to mBSA immunization was examined in draining inguinal lymph node cells. A 50% reduction in cellularity was observed in PI3Kγ KD/KD lymph nodes when compared to WT lymph nodes (Fig. 10C) . Lymph node cells mounted an Ag-specific response to mBSA ex vivo stimulation in a dose-dependent fashion and the proliferative response of PI3Kγ KD/KD lymph node cells was reduced by 56 to 64% when compared to WT cells (Fig. 10D) .
Discussion
Despite the discovery of PI3Kγ as a unique member of the class I PI3K family coupled with distinct regulatory subunits for GPCR signaling in immune cells, the role of PI3Kγ in T cell-mediated immunity remains elusive. The function of PI3Kγ as a signaling protein involves its lipid kinase activity as well as its scaffolding function [1, 7] . Studies on PI3Kγ biology have largely been based on the functional defects shown in PI3Kγ knockout mice or with inhibitor treatments [8-10, 26, 29] . These approaches have provided valuable information furthering the understanding of the biological functions of PI3Kγ; there are, however, limitations in interpretation of the results from these studies. The lack of PI3Kγ expression in knockout mice does not allow dissection of PI3Kγ kinase activity from its adaptor function. PI3Kγ inhibitors block kinase activity specifically and are, therefore, useful tools to demonstrate the importance of PI3Kγ kinase activity. However, due to the challenge in generating highly selective and potent PI3Kγ inhibitors, compound effects could be due to off-target activities. We therefore took the biological approach to use PI3Kγ KD/KD mice to define the role of PI3Kγ kinase activity on T cells. We examined the activation of PI3Kγ KD/KD T cells with different stimuli including anti-CD3 alone or in combination with anti-CD28. The partial defects in T-cell proliferation and cytokine production could be demonstrated in both stimulations, and the defects could not be rescued with exogenous IL-2. The physiological relevance of this impairment was confirmed with Ag-specific stimulations in vitro and in vivo. In MLRs, the response of PI3Kγ KD/KD T cells to allogeneic cells was reduced. be overcome by increasing the strength of the stimuli, such as combination of anti-CD3 and anti-CD28 or high concentrations of Ags. Furthermore, defects could be shown in different T-cell subsets including CD4
+ and CD8 + T cells, as well as naïve, memory, and effector T cells. Taken together, we have demonstrated here that PI3Kγ kinase activity is needed for optimal T-cell activation, although its role is not dominant and the lack of PI3Kγ kinase activity does not abolish T-cell activation completely. The involvement of PI3Kγ kinase activity in T-cell polarization was explored in different stimulation conditions. Naïve PI3Kγ The defects demonstrated in PI3Kγ KD/KD T cells are similar to the phenotype reported for PI3Kγ knockout mice [8] [9] [10] , suggesting that the kinase activity could be the key function of PI3Kγ in T cells. This finding has an important implication to drug discovery since PI3Kγ inhibitors only block kinase activity but not adaptor function, and the results predict the potential efficacy of PI3Kγ inhibitors in the immune system. There is, however, a recent report suggesting an enhanced IL-17A production and Th17 differentiation from PI3Kγ deficient T cells [12] . One possible explanation for the different findings is that our results are from T cells defective in PI3Kγ kinase activity whereas this report is based on T cells defective in PI3Kγ expression. Further studies are, therefore, needed to clarify the discrepancies. The role of PI3Kγ kinase activity on T cells identified in our studies also resembles the biological effects of PI3Kδ [30, 31] . In fact, PI3Kγ and PI3Kδ are closely related in their biological properties. Both of them are expressed in cells of hematopoietic lineage, unlike the ubiquitous expression of other members PI3Kα and PI3Kβ. They are not dominant players in T-cell functions and the lack of their activities only reduces but does not abolish completely the response of T cells. Furthermore, their kinase activities are essential for their biological effects in T cells. Since they utilize different regulatory subunits for their signaling activities, it is possible that the role of PI3Kγ and PI3Kδ in TCR signaling does not completely overlap and dual target inhibition may achieve a better efficacy in blocking T-cell activation.
PI3Kγ signaling is known to be downstream of GPCR through interaction with G βγ proteins [4, 5] . The mechanism of PI3Kγ involvement in TCR signaling is still largely unknown. It remains a key question as to whether PI3Kγ is directly involved in TCR signaling or indirectly through its participation in signaling of the GPCRs that function as TCR signaling mediators. Investigation of the defective mechanisms in PI3Kγ KD/KD T cells revealed a decrease in TCR-mediated phosphorylation of AKT and ERK1/2, which could be compensated by TCR/CD28 stimulation, a defect in lipid raft aggregation, and a delay in cell cycle progression. It is possible that the lack of PI3Kγ kinase activity causes a defect in TCR signaling that results in a delay in cell cycle progression and eventually leads to a decrease in T-cell differentiation.
Here we have shown that PI3Kγ kinase activity contributes to T-cell activation, differentiation, and chemotaxis. Defects in T-cell response in vitro correlate with the reduced immune response in immunization and DTH models in PI3Kγ KD/KD mice. These mice have normal natural Treg-cell population and do not seem to succumb to spontaneous autoimmune diseases, suggesting that Treg cells are functional for immune regulation in these mice. Indeed, PI3Kγ-deficient mice are also shown to be protected in a number of disease models including arthritis, psoriasis, lupus, colitis, experimental autoimmune encephalomyelitis, atherosclerosis, and asthmatic models [29, [32] [33] [34] [35] [36] [37] [38] . It should be noted that the in vivo results could potentially be partly coming from minor T-cell developmental defects observed in PI3Kγ KD/KD and PI3Kγ-deficient mice [8] (our unpublished data). A definitive proof of PI3Kγ kinase activity on immune response in vivo may still rely on the availability of inducible PI3Kγ KD/KD mouse models or highly selective PI3Kγ inhibitors. Our results with the PI3Kγ KD/KD mice suggest a kinase-dependent role of PI3Kγ in T-cell immunity and support the notion that PI3Kγ kinase inhibitors could be beneficial in treatment of T cell-mediated autoimmune and inflammatory diseases. As we have demonstrated in this report, inhibition of PI3Kγ kinase activity but not its adaptor function could be an ideal scenario in drug discovery to achieve efficacy while avoiding possible cardiovascular liabilities. It is, therefore, imperative for both basic research and drug discovery to understand the molecular mechanism of PI3Kγ signaling and its functional role in the immune system. 
Materials and methods

Mice
Cytokine ELISA assays
Cytokines in T-cell culture supernatants were measured in ELISA assays using Ab pairs for IL-2, IL-4, and IFN-γ (BD Biosciences) and IL-17A ELISA kit (R&D) following the kit protocols.
T-cell signaling assays
T cells were coated with 1 μg/mL of antimouse CD3ε (Biolegend) alone or in combination with anti-CD28 (Biolegend), followed by coupling with 1 μg/mL of goat antihamster IgG (Pierce). T cells before and after stimulation were lysed with NP-40 lysis buffer containing protease inhibitors (Invitrogen). Lysates were separated by electrophoresed and blotted onto polyvinylidene difluoride (PVDF) filters (Bio-Rad). AKT, ERK, and their phosphorylated forms, as well as PI3Kγ p110 were detected and quantitated in Western blots using specific antibodies (Cell Signaling Technology) following the protocols of reagent kits.
T-cell phenotyping in flow cytometry
T cells were stained with fluorescent dye conjugated antibodies specific for different cell surface markers (eBioscience) according to standard staining procedures. Intracellular staining was performed by stimulating T cells for 4 h with a leukocyte activation cocktail containing GolgiPlug (BD Biosciences), followed by fixing with paraformaldehyde (Biolegend) and permeabilization with saponin buffer (Biolegend), and then staining with antibodies (eBioscience) according to kit protocols. Cell division was detected by staining T cells with 1 μM CFSE (Invitrogen) prior to activation or differentiation assays. Samples were acquired with FACSCalibur (BD Biosciences) and analyzed with FlowJo software (Tree Star).
T-cell differentiation assays
Naive CD4 + T cells were activated with plate-bound anti-CD3 (1 μg/mL) and soluble anti-CD28 (2.5 μg/mL) under different polarizing conditions. Th1 differentiation was driven by 20 U/mL IL-12, 100 U/mL IL-2, and 10 μg/mL anti-IL-4. Th2 differentiation condition was set up with 200 U/mL IL-4, 100 U/mL IL-2, and 10 μg/mL each of anti-IL12 and anti-IFN-γ. Th17 polarization was prepared with 5 ng/mL TGF-β, 20 ng/mL IL-6, and 10 μg/mL each of anti-IL-4 and anti-IFN-γ (all reagents form ReproTech). Treg-cell differentiation condition was set by addition of 5 ng/mL TGF-β1 and 100 U/mL IL-2 in medium. After 6 days of differentiation, T cells were characterized by intracellular staining of cytokines and transcription factors as described in the earlier section on T-cell phenotyping. Differentiation of Ag-specific T cells was performed with naïve CD4 + T cells from OT-II transgenic mice. Transgenic T cells were stimulated for 6 days with 0.5 μM ovalbumin peptide OVA323-339 (ISQAVHAAHAEINEAGR, Anaspec) in the presence of mitomycin C-treated splenocytes under Th1 or Th17 differentiation condition.
Lipid raft immunofluorescence staining
CD4
+ T cells were incubated with anti-CD3-or anti-CD3-coated plus anti-CD28-coated polystyrene beads (Spherotech) at 1:5 cell/bead ratio at 37
• C for 30 min followed by cell attachment onto poly-L-lysine-coated slides (BD Pharmaceuticals). Cells on slides were treated with 3.7% paraformaldehyde in PBS for 10 min, permeabilized with 0.1% Triton X-100 in PBS for 10 min, and then blocked with 1% BSA in PBS for 30 minu. Cells were then incubated with FITC-conjugated cholera toxin B (Sigma) for 1 h, washed with PBS, and mounted onto slides with Vectashield containing 4 , 6 -diamidino-2-phenylindole (Vector Laboratories). Cells on slides were examined using a Leica SPE2 confocal microscope system with Zeiss 63 × 1.4 oil objectives and SlideBook 4.2 software (Intelligent Imaging Innovations). Cholera toxin Bstained lipid rafts at cell/bead contact areas were evaluated visually on ∼150 cell/bead conjugates.
T-cell chemotaxis assays
Chemotaxis assays were performed in transwell plates with uncoated filters of 5 μm pore size (Corning Coastar). Splenocytes were placed at the upper chamber at 2 × 10 6 cells/well and chemokine CCL3 (0.27 μg/mL), CCL19 (0.2 μg/mL), CCL21 (0.5 μg/mL), CXCL12 (3 μg/mL), or RANTES (0.1 μg/mL, R&D Systems) was added in the lower chamber. T cells entered in the lower chamber after 1 h of incubation were quantitated by acquisition with FACSCalibur.
Ovalbumin immunization
PI3Kγ KD/KD mice backcrossed to C57BL/6 background and WT C57BL/6 mice were immunized at tail base with 200 μg ovalbumin (Grade V, Sigma-Aldrich) emulsified with CFA (BD Diagnostics) at 1:1 volume ratio. For ovalbumin/alum immunization, BALB/cJ mice and PI3Kγ KD/KD mice of BALB/cJ background were immunized at tail base with 50 μg ovalbumin (Grade V, SigmaAldrich)/alum mixture. Ovalbumin/alum mixture was prepared by mixing 200 μg/mL ovalbumin in PBS with 4% Imject Alum (Pierce) at 1:1 volume ratio and incubated for 1 h at room temperature. On day 10, postimmunization, mice were sacrificed and the draining inguinal lymph nodes were collected and cell suspensions were prepared for cell count, intracellular cytokine detection, and proliferation assays. Draining lymph node cells from ovalbumin/CFA immunized mice were stimulated with ovalbumin ex vivo at 5 × 10 5 cells/well for 3 days. Cell proliferation and cytokine production were measured with methodologies as described in T-cell proliferation section.
Delayed-type hypersensitivity model
C57BL/6J mice and PI3Kγ KD/KD mice were immunized at tail base with 100 μL of 1 mg/mL mBSA (Sigma) in 1:1 volume CFA emulsion (Difco; BD Diagnostics). On day 7 mice were challenged by injecting 50 μL of 180 μg/mL mBSA into left footpads and 50 μL of saline into right footpads as negative controls. Footpad thickness was measured with a caliper at 0, 6, 26, 29.5, and 48 h time points. On day 11, mice were sacrificed and inguinal nodes were collected to prepare cells for proliferation assays. Paws were collected and fixed in 10% formalin, decalcified with formic acid, processed, and longitudinally embedded in paraffin. Serial 5 μm sections were prepared and stained with H&E for histology evaluation. Tissue was scored for inflammation, edema, hemorrhage, and subcutaneous necrosis. Each parameter was scored as follows: 0 = Normal, 1 = Mild, 2 = Moderate, 3 = Moderately severe, 4 = Markedly Severe. A summary histological score for severity of inflammation was accounted as summary of all the parameters. Draining inguinal lymph node cells from mBSA immunized mice were stimulated with different concentrations of mBSA at 5 × 10 5 cells/well for 3 days. Cell proliferation and cytokine production was measured as described previously.
